Cell Reports (May 2016)

Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a

  • Staci L. Haney,
  • G. Michael Upchurch,
  • Jana Opavska,
  • David Klinkebiel,
  • Ryan A. Hlady,
  • Abhinav Suresh,
  • Samuel J. Pirruccello,
  • Vipul Shukla,
  • Runqing Lu,
  • Stefan Costinean,
  • Angie Rizzino,
  • Adam R. Karpf,
  • Shantaram Joshi,
  • Patrick Swanson,
  • Rene Opavsky

DOI
https://doi.org/10.1016/j.celrep.2016.04.004
Journal volume & issue
Vol. 15, no. 6
pp. 1190 – 1201

Abstract

Read online

DNA methyltransferase 3a (DNMT3A) catalyzes the formation of 5-methyl-cytosine in mammalian genomic DNA, and it is frequently mutated in human hematologic malignancies. Bi-allelic loss of Dnmt3a in mice results in leukemia and lymphoma, including chronic lymphocytic leukemia (CLL). Here, we investigate whether mono-allelic loss of Dnmt3a is sufficient to induce disease. We show that, by 16 months of age, 65% of Dnmt3a+/− mice develop a CLL-like disease, and 15% of mice develop non-malignant myeloproliferation. Genome-wide methylation analysis reveals that reduced Dnmt3a levels induce promoter hypomethylation at similar loci in Dnmt3a+/− and Dnmt3aΔ/Δ CLL, suggesting that promoters are particularly sensitive to Dnmt3a levels. Gene expression analysis identified 26 hypomethylated and overexpressed genes common to both Dnmt3a+/− and Dnmt3aΔ/Δ CLL as putative oncogenic drivers. Our data provide evidence that Dnmt3a is a haplo-insufficient tumor suppressor in CLL and highlights the importance of deregulated molecular events in disease pathogenesis.